Medical News

RSS

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has granted final approval for the Company's generic versions of Merck's antihypertensive agents Hyzaar® (hydrochlorothiazide; losartan potassium) and Cozaar® (losartan potassium).

8 Apr 2010

Allscripts' third-quarter revenues rise up 12%

Allscripts-Misys Healthcare Solutions, Inc. today announced its financial results for the three and nine months ended February 28, 2010.

8 Apr 2010

Arizona and Nevada Governors reject AGs' advice, join suit against new health law

The Associated Press/Boston Globe: "The governors of Arizona and Nevada say their states will join 14 others suing the federal government over health care reform. Gov. Jan Brewer announced Arizona was joining the suit Tuesday night. She signed a bill April 1 that gave her the authority to skirt the state's Democratic attorney general, Terry Goddard, who declined to sue on the state's behalf.

8 Apr 2010

Queensland Health pay bungle continues

Either you get overpaid or you don’t get paid at all, that’s how Queensland Health’s casual staff seem to feel. Last week a payroll system which was blamed for overpaying the Queensland Health Staff was replaced with a new one. The new system cost $40 million to develop, but in the opinion of the staff is worse than the old one. A number of them have not been paid at all.

8 Apr 2010

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Torax Medical Inc., a medical device company focused on the minimally invasive treatment of gastro-esophageal reflux disease (GERD), has received CE Mark for its LINX® Anti-Reflux treatment. The company has started commercial launch of the LINX device at select centers in Europe.

8 Apr 2010

Today's opinions and editorials

From an economic perspective, health reform will fail if we can't sometimes push back against the try-anything instinct (David Leonhardt, 4/6).

8 Apr 2010

Is grandmother’s age significant to autism?

A report just published in the online journal, PLoS ONE, indicates that the mothers of children with an autistic spectrum disorder were themselves more likely to have been born to older mothers. These findings could open up new avenues in autism research.

8 Apr 2010

$Women unaware of risk of dangerous osteoporosis fractures$

Women unaware of risk of dangerous osteoporosis fractures

Only one in three Australian women diagnosed with osteoporosis are aware they are at higher risk of sustaining debilitating bone fractures, according to a landmark international study published with input from University of Sydney researchers.

7 Apr 2010

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

DURECT Corporation announced today that its licensee, King Pharmaceuticals, has begun a Phase IIb clinical trial to evaluate ELADUR™ (TRANSDUR™-Bupivacaine) for the treatment of chronic low back pain. ELADUR is an investigational transdermal drug patch intended to deliver bupivacaine for up to 3 days from a single application.

7 Apr 2010

Valeant Pharmaceuticals International prices $400M of 7.625% senior unsecured notes due 2020

Valeant Pharmaceuticals International announced today that it has priced its previously announced private placement of $400 million of 7.625% senior unsecured notes due 2020. The principal amount was increased from the previously announced $350 million.

7 Apr 2010

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced the initiation of a Phase 1 trial of CAL-101, the Company's oral, PI3K delta inhibitor, in combination with standard of care agents Rituxan® (rituximab) and/or Treanda® (bendamustine) in patients with relapsed or refractory indolent non-Hodgkin's lymphoma or chronic lymphocytic leukemia.

7 Apr 2010

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.

7 Apr 2010

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

More than $72.3 billion was committed to fund 291 managed care mergers and acquisitions announced during the 10-year period ended December 31, 2009, according to DealSearchOnline.com. UnitedHealth Group was the acquirer in 10 of the top 25 managed care mergers and acquisitions announced during 10-year period ended December 31, 2009.

7 Apr 2010

Low-skilled workers to perform initial blood donor screening: ONA, CFNU question decision

The Ontario Nurses' Association (ONA) has joined the Canadian Federation of Nurses Unions (CFNU) in questioning the decision of federal health minister Leona Aglukkaq to allow Canadian Blood Services to conduct a pilot project to replaces nurses with low-skilled workers for initial blood donor screening.

7 Apr 2010

AMP Agency appointed media agency of record for LexisNexis's U.S. Legal Markets business unit

AMP Agency, a full service marketing agency, today announced it has been appointed the media agency of record for the U.S. Legal Markets business unit of LexisNexis and the Netter Anatomy brand of Elsevier. LexisNexis and Elsevier are both part of Reed Elsevier. LexisNexis® is a leading global provider of content-enabled workflow solutions designed specifically for legal, corporate, government, and academic professionals.

7 Apr 2010

Sitting down during hospital room visits induces perception of having stayed longer

Sitting down on the job has its advantages. New data from The University of Kansas Hospital finds that patients perceive doctors who sit down during their hospital room visits stay longer than doctors who stand during the visit – even when doctors who sit don't stay as long as doctors who stand.

7 Apr 2010

ASPIRE 2010 focuses on A.R.T. issues

Infertility, defined as the failure to conceive after 12 months or more of regular, unprotected intercourse, may affect as many as 15 percent of couples around the world including Asia. Like other countries, China's infertility rate is on the rise increasing from 3 percent to 15 percent in the past 20 years. It is estimated that at least 40 million Chinese couples have difficulty in having children or are actually infertile.

7 Apr 2010

BeaconEquity.com releases investment report on Cell Therapeutics

BeaconEquity.com announces an investment report featuring biotech company Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

7 Apr 2010

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, today provided a penultimate update regarding the three-year follow up of its Phase I/IIa clinical trial in Russia of its DIABECELL® treatment in insulin-dependent diabetics.

7 Apr 2010

MAP Pharmaceuticals to present additional data from FREEDOM-301 Phase 3 trial of LEVADEX at AAN meeting

MAP Pharmaceuticals, Inc. today announced the Company will present additional post-hoc analyses from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy in two patient subpopulations that are often difficult to treat with current triptan migraine therapies: menstrual migraine and migraine with allodynia.

7 Apr 2010

Medical News

FDA grants final approval for Teva Pharmaceutical Industries' generic Hyzaar and Cozaar

Allscripts' third-quarter revenues rise up 12%

Arizona and Nevada Governors reject AGs' advice, join suit against new health law

Queensland Health pay bungle continues

Torax Medical's LINX Anti-Reflux treatment receives CE Mark approval

Today's opinions and editorials

Is grandmother’s age significant to autism?

Women unaware of risk of dangerous osteoporosis fractures

King Pharmaceuticals commences Phase IIb clinical trial of ELADUR for chronic low back pain

Valeant Pharmaceuticals International prices $400M of 7.625% senior unsecured notes due 2020

Calistoga Pharmaceuticals commences CAL-101 trial in combination with Rituxan and/or Treanda

Cytrx to commence Phase 2 trial of bafetinib for advanced prostate cancer

DealSearchOnline.com announces $72.3B committed to fund 291 managed care mergers and acquisitions

Low-skilled workers to perform initial blood donor screening: ONA, CFNU question decision

AMP Agency appointed media agency of record for LexisNexis's U.S. Legal Markets business unit

Sitting down during hospital room visits induces perception of having stayed longer

ASPIRE 2010 focuses on A.R.T. issues

BeaconEquity.com releases investment report on Cell Therapeutics

Updates from Phase I/IIa clinical trial of DIABECELL treatment in insulin-dependent diabetics

MAP Pharmaceuticals to present additional data from FREEDOM-301 Phase 3 trial of LEVADEX at AAN meeting

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News